Pharmaceuticals companies may be affected by industry competition, dependency on a limited number of products, obsolescence of products, government approvals and regulations, loss or impairment of intellectual property rights and litigation regarding product liability
They are offering clients a more complete one-stop brand service that can include planning, package design, formulation development, and on-site project management
Melanotan I is a synthetic linear tridecapeptide analogue of alpha-melanocyte-stimulating hormone, sequence Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH (CHNO, 1646.9 g/mol, CAS 75921-69-6), catalogued in the literature as afamelanotide, as NDP-alpha-MSH, and in analogue notation as [Nle, D-Phe]-alpha-MSH
However, individual variation is enormous
Gonzlez-Garca, I., Gruber, T